These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3309705)

  • 1. [Use of drugs inhibiting blood platelet activity in the treatment of cerebral ischemia].
    Kuczyńska-Zardzewiały A; Członkowska A
    Neurol Neurochir Pol; 1987; 21(2):154-60. PubMed ID: 3309705
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of antiaggregants in patients with neurocirculatory asthenia with the initial signs of cerebral ischemia].
    Lebedev AA; Burdakov VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):48-52. PubMed ID: 2158726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet function and antiaggregant therapy in ischemic stroke.
    Pettigrew LC; Wu KK
    Semin Neurol; 1986 Sep; 6(3):293-8. PubMed ID: 3332433
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of acetylsalicylic acid and diquertin on platelet aggregation and hemorheological parameters in rats with cerebral ischemia].
    Plotnikova MB; Iamkin aV; Aliev OI; Tiukavkina NA
    Eksp Klin Farmakol; 2005; 68(2):33-5. PubMed ID: 15934364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiaggregation therapy in cerebral ischemia].
    Jovicić A; Ivanisević V; Marić D
    Vojnosanit Pregl; 1993; 50(5):503-10. PubMed ID: 8128651
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiaggregation therapy is a secondary prevention of ischemic stroke].
    Kamchatov PR; Chugunov AV; Umarova KhIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 23():58-64. PubMed ID: 19425370
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
    Pongrácz E
    Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on "hyperresponsiveness of platelets in ischemic stroke" by Fateh-Moghadam et al.
    Smout J; Cleanthis M; Stansby G
    Thromb Haemost; 2008 Jan; 99(1):239. PubMed ID: 18217162
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective mechanisms of inosine in platelet activation and cerebral ischemic damage.
    Hsiao G; Lin KH; Chang Y; Chen TL; Tzu NH; Chou DS; Sheu JR
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1998-2004. PubMed ID: 15976325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelets, atherothrombosis, antiplatelet drugs and cerebral ischemia].
    Bousser MG
    Bull Acad Natl Med; 2013 Feb; 197(2):389-94. PubMed ID: 24919368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction.
    D'Andrea G; Perini F; Hasselmark L; Alecci M; Cananzi AR
    Funct Neurol; 1995; 10(2):91-8. PubMed ID: 7557557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The antiaggregation activity of the normal cerebral vessels and in ischemia].
    Petrishchev NN; Shestakova SA; Dorokhova LN; Mel'nikova EV
    Fiziol Zh SSSR Im I M Sechenova; 1989 Nov; 75(11):1515-20. PubMed ID: 2628008
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aggregation inhibitors for treatment of the acute phase of cerebral ischemia].
    Szczepańska-Szerej A
    Ann Univ Mariae Curie Sklodowska Med; 1995; 50():131-6. PubMed ID: 9304381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet/von Willebrand factor inhibitors to the rescue of ischemic stroke.
    Mannucci PM
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1882-4. PubMed ID: 20844269
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological and therapeutic features of cerebral ischemic conditions].
    Lechner H; Schmidt R
    Ric Clin Lab; 1988; 18 Suppl 2():59-64. PubMed ID: 3247563
    [No Abstract]   [Full Text] [Related]  

  • 17. [Platelet anti-aggregants, from the concept to clinical results].
    Tobelem G
    Rev Prat; 1988 Dec; 38(30):2268-71. PubMed ID: 3222655
    [No Abstract]   [Full Text] [Related]  

  • 18. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator.
    Maeda M; Moriguchi A; Mihara K; Aoki T; Takamatsu H; Matsuoka N; Mutoh S; Goto T
    J Cereb Blood Flow Metab; 2005 Jan; 25(1):108-18. PubMed ID: 15678117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of berberine on platelet aggregation and plasma levels of TXB2 and 6-keto-PGF1 alpha in rats with reversible middle cerebral artery occlusion].
    Wu JF; Liu TP
    Yao Xue Xue Bao; 1995; 30(2):98-102. PubMed ID: 7785438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.